ID
27970
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 12/7/17 12/7/17 -
- 12/31/17 12/31/17 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 7, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Patient Status GOAL Trial B-cell Lymphoma NCT02499003
Patient Status GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Patient status
Description
If 'Patient alive':
Description
Date of follow up
Data type
date
Description
Progression after last contact
Data type
text
Description
Date of diagnosis of progression
Data type
date
Description
Means of diagnosis
Data type
text
Description
means of diagnosis specification
Data type
text
Description
If 'Patient deceased':
Similar models
Patient Status GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM